Global Endobronchial Ultrasound Biopsy Market Drivers
The global endobronchial ultrasound biopsy market is expected to witness significant growth over forecast period, owing to increasing prevalence of lung cancer among people globally. For instance, according to World Health Organization (WHO), around 2.09 million people suffered from lung cancer, while 1.76 million deaths were reported due to lung cancer, in 2018, globally.
Furthermore, according to the Cancer Research UK, lung cancer is the third most common cancer in the U.K. and accounted for 13% new cancer cases in 2017. In addition, according to the same source, in 2017, 25,000 new cases of lung cancer were reported in men, while 22,300 new cases of lung cancer in women. From the same source, incidence rate of lung cancer in the U.K. was highest in people aged 85 to 89 years, from 2015 to 2017.
Global Endobronchial Ultrasound Biopsy Market Restraints
However, complication related to sedation such as hypoxemia and hypotension that can occur during performing bronchoscopy procedures is one of the major restraints that is expected to hamper the global endobronchial ultrasound biopsy market growth.
Moreover, in lung cancer, endobronchial ultrasound is unable to stage entire mediastinum, and it is limited to anterosuperior mediastinum. Moreover, in some anatomic location such as upper lobes, endobronchial ultrasound is difficult to perform. Therefore, these factors are expected to hamper the global endobronchial ultrasound biopsy market growth over the forecast period.
Endobronchial Ultrasound Biopsy Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients